Japan Clears First Human Genetic Diagnostic Reagent For Marketing
This article was originally published in PharmAsia News
Executive Summary
Japan's Health Ministry cleared for production the first human genetic diagnostic reagent to be made in the country. Sekisui Medical, a subsidiary of Sekisui Chemical, got approval for the product designed to determine if irinotecan hydrochloride drugs would have severe side effects for cancer patients. Sekisui plans to sell the reagent as a general diagnostic test as early as next spring. Some patients experience severe diaarhea and vomiting after taking the drug. (Click here for more - a subscription may be required